Literature DB >> 1593581

Frequency and specificity of antibodies that crossreact with Borrelia burgdorferi antigens.

P T Fawcett1, K M Gibney, C D Rose, S B Dubbs, R A Doughty.   

Abstract

The frequency and specificity of antibodies that bind antigens of Borrelia burgdorferi in sera from 200 individuals with no evidence of past or current Lyme disease was determined. Sera were tested for both IgG and IgM antibodies to B. burgdorferi by Western blotting. The non-Lyme serum group included specimens from healthy adults and children in addition to specimens from patients with viral infection and rheumatic diseases. Crossreactive IgG antibodies occurred more frequently than IgM antibodies. The most frequently bound antigens corresponded to 41 kDa and 60 kDa Borrelial components. Of 200 specimens tested, 100 had antibodies that bound at least 1 antigen. Binding to multiple antigens occurred at much lower frequency. Our results indicate that determination of maximum crossreactivity of non-Lyme sera can be used to establish minimum criteria for determining a positive Western blot result for Lyme disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1593581

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  17 in total

1.  In vitro assessment of antiborrelial activity of OspA vaccine sera.

Authors:  Paul T Fawcett; Carlos D Rose; Kathleen M Gibney
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

2.  Comparison of immunodot and western blot assays for diagnosing Lyme borreliosis.

Authors:  P T Fawcett; C D Rosé; K M Gibney; R A Doughty
Journal:  Clin Diagn Lab Immunol       Date:  1998-07

3.  New laboratory guidelines for serologic diagnosis of Lyme disease: evaluation of the two-test protocol.

Authors:  T B Ledue; M F Collins; W Y Craig
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

4.  Collection and characterization of samples for establishment of a serum repository for lyme disease diagnostic test development and evaluation.

Authors:  Claudia R Molins; Christopher Sexton; John W Young; Laura V Ashton; Ryan Pappert; Charles B Beard; Martin E Schriefer
Journal:  J Clin Microbiol       Date:  2014-08-13       Impact factor: 5.948

5.  False positive ELISA serologic test for Lyme borreliosis in patients with connective tissue diseases.

Authors:  B Keymeulen; G Somers; A Naessens; L A Verbruggen
Journal:  Clin Rheumatol       Date:  1993-12       Impact factor: 2.980

Review 6.  Lyme arthritis.

Authors:  D H Rees; J S Axford
Journal:  Ann Rheum Dis       Date:  1994-09       Impact factor: 19.103

7.  Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans.

Authors:  M E Aguero-Rosenfeld; J Nowakowski; S Bittker; D Cooper; R B Nadelman; G P Wormser
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

Review 8.  Tick-borne encephalopathies : epidemiology, diagnosis, treatment and prevention.

Authors:  Göran Günther; Mats Haglund
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

9.  Effect of immunization with recombinant OspA on serologic tests for Lyme borreliosis.

Authors:  P T Fawcett; C D Rose; S M Budd; K M Gibney
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

10.  Long-term effects of immunization with recombinant lipoprotein outer surface protein a on serologic test for lyme disease.

Authors:  Paul T Fawcett; Carlos D Rose; Victoria Maduskuie
Journal:  Clin Diagn Lab Immunol       Date:  2004-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.